CVS Health Stock Is Beating the Market in 2026.
Here’s Why Wall Street Thinks It Can Soar Another 22%
One of the hotter stocks in big healthcare just now is pharmacy chain mainstay CVS Health (NYSE: CVS). The company’s shares have raced more than 18% higher year to date, comparing favorably to the benchmark S&P 500 index’s sub-13% rise. And, according to most analysts tracking the stock, the stock’s not done yet.
According to data compiled by TipRanks, the consensus pundit price target is $114.59 per share, which is 22% above its most recent closing level. Let’s open the doors of this busy pharmacy to determine how it got here, and whether it can indeed continue to move higher. Beating analysts’ earning estimates Any company that delivers two estimates-crushing quarters in a row is going to be a juicy buy candidate for investors.